MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma


The prognosis of hepatocellular carcinoma (HCC) treated by radiofrequency ablation (RFA) is mainly associated with tumor recurrence. So far, no tissue biomarker of recurrence has been confirmed in biopsy specimens. Previous studies have reported that aberrant expression of microRNA-34a (miR-34a) is involved in oncogenesis and progression of HCC. The aim of… (More)
DOI: 10.1007/s13277-014-3031-5


5 Figures and Tables